All of this is trial data, not a safety guarantee
Prog Polym Sci 37(8):10791104 Lee W, Pinckney J, Lee V, Lee J-H, Fischer K, Polio S et al (2009) Three-dimensional bioprinting of rat embryonic neural cells
Rosiglitazone (a 2nd generation thiazolidinedione) has been recently associated with cardiovascular complications, and it is being used only in a few countries with severe restrictions
Mean arterial pressure (MAP): necessary, but not sufficient MAP remains central because it reflects the steady component of arterial pressure and correlates with organ perfusion
However, given the current statutory requirement, which allows us to reassess the methodology every 3 years, there is no requirement that prevents us from setting the methodology for a longer time frame
It is not approved for human medical use